<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">On the other hand, we cannot forget that this situation due to COVID-19 pandemic is very difficult to face for any people with DM. Due to the restrictions applied by many Governments, the latter have to face hard challenges in getting the needed treatments as well as the required support by the specialists or other health care professionals. The seriousness of the epidemic has obviously triggered Associazione Medici Diabetologi (AMD) and Societ√† Italiana Diabetologia (SID), two of the most relevant national scientific societies in the field, which immediately complemented the efforts of Italian Government by strengthening social distancing messages and providing guidelines for their members on how to handle clinical cases during the period 
 <xref rid="b0265" ref-type="bibr">[53]</xref>. They also developed innovative strategies to reduce mortality risk of people with DM from the very beginning by preventing hospitalization as much as possible through a hotline to call for help 
 <xref rid="b0270" ref-type="bibr">[54]</xref> and enhanced home management. To do so, they made a joint telemedicine effort to have several diabetologists available 7/7 days to take turn for on line advice for drug dosage adaptation needs or any other remotely manageable medical emergencies 
 <xref rid="b0275" ref-type="bibr">[55]</xref>.
</p>
